The DopaFuse Delivery System is a patented, intra-oral system that continuously and noninvasively delivers levodopa and carbidopa at a controlled rate for patients with PD. The DopaFuse System consists of an oral retainer, its case, and a prefilled, single-use drug container that continuously releases a levodopa-carbidopa paste in the back of the mouth.
Phase 2 Clinical Trial of DopaFuse Delive... - Cure Parkinson's
Phase 2 Clinical Trial of DopaFuse Delivery System
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Written by
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Farooqji
To view profiles and participate in discussions please or .
Read more about...
4 Replies
•
Exciting! HWP has really experienced improved OFF times with Duopa but gets tired of lugging the pump around.
I see little sense in feeding continuously unless they do something about the bacteria that may be feeding on your meds in your gut. Item 1 in linked post.
Not what you're looking for?
You may also like...
A new delivery system option.
are using the Rpi as a multi-channel sound delivery system. to drive small speakers to stimulate...
UC study: Subcutaneous infusion pump safe, effective for Parkinson’s treatment
Levodopa is most commonly administered orally, but this trial tested continuous, 24-hour levodopa...
A (minor) update by Inhibikase Therapeutics on their Phase 2 trial of Risvodetinib (IkT-148009) for Parkinson's Disease.
date given in the trial record].\\"...